Diagnosis and Management of Tics
Diagnosis
Tic disorders are diagnosed clinically based on the presence of core features: suppressibility, distractibility, suggestibility, variability, waxing-waning pattern, and premonitory sensations—not by cough characteristics or timing. 1, 2
Essential Diagnostic Criteria
- Tourette Syndrome requires multiple motor tics AND at least one vocal tic persisting for ≥1 year with childhood onset 1, 2
- Chronic Motor or Vocal Tic Disorder presents with only motor OR vocal tics (not both) lasting >1 year 3
- Transient Tic Disorder resolves within 1 year and affects 4-24% of elementary school children 1, 3
Clinical Features to Identify
Simple motor tics include eye blinking, facial grimacing, head jerking, and shoulder shrugging 1, 3
Simple phonic tics include throat clearing, sniffing, grunting, coughing, squeaking, and barking 2, 3
Core distinguishing features:
- Patients can temporarily suppress tics voluntarily, followed by intensification of premonitory urges 2, 3
- Tics wax and wane in severity over weeks to months 2, 3
- Tics are modifiable by distraction and suggestion 3
Critical Diagnostic Pitfalls to Avoid
- Do NOT use nighttime cough or barking/honking quality to diagnose or exclude tic disorders—these lack specificity 4
- Abandon outdated terminology: Replace "habit cough" with "tic cough" and "psychogenic cough" with "somatic cough disorder" per DSM-5 classification 4, 1
- Avoid excessive medical testing—diagnosis is primarily clinical and unnecessary workup causes iatrogenic harm 1, 2
- Do not misdiagnose tics as habit behaviors or psychogenic symptoms, which leads to inappropriate interventions 1, 2
Mandatory Comorbidity Screening
Screen ALL patients for:
- ADHD (present in 50-75% of children with Tourette's) 1, 2, 3
- OCD or obsessive-compulsive behaviors (present in 30-60% of cases) 1, 2, 3
Required Assessment
A multidisciplinary evaluation by neurologist, psychiatrist, and psychologist is necessary for comprehensive diagnosis 1, 2
Management
Behavioral interventions—specifically habit reversal training (HRT) and exposure with response prevention (ERP)—are first-line treatment before any pharmacological options. 1
Treatment Algorithm
Step 1: Education and Watchful Waiting
- Educate patient/family about natural history: nearly 50% experience spontaneous remission by age 18 1
- For mild symptoms or suspected transient tic disorder, avoid medications initially 1
Step 2: First-Line Behavioral Therapy
- Habit reversal training (HRT) and exposure with response prevention (ERP) should be initiated before medications 1
- ERP involves deliberately experiencing premonitory sensations without performing the tic 1
Step 3: First-Line Pharmacotherapy (if behavioral therapy insufficient)
Alpha-2 adrenergic agonists (clonidine or guanfacine) are preferred first-line medications, especially when comorbid ADHD or sleep disorders are present 1
- Provide "around-the-clock" effects and are uncontrolled substances 1
- Expect 2-4 weeks until therapeutic effects observed 1
- Monitor pulse and blood pressure regularly 1
- Common adverse effects: somnolence, fatigue, hypotension—administer in evening 1
- For comorbid ADHD with tics: atomoxetine or guanfacine are preferred as they may improve both conditions simultaneously 1
Critical point: Stimulants can be used safely in children with tics and ADHD—multiple double-blind placebo-controlled studies demonstrate efficacy, and stimulants should NOT be withheld based on outdated concerns 1
Step 4: Second-Line Pharmacotherapy
Anti-dopaminergic medications (haloperidol, pimozide, risperidone, aripiprazole) are effective but carry higher risk 1
Risperidone dosing:
- Start 0.25 mg daily at bedtime, maximum 2-3 mg daily in divided doses 1
- Monitor for extrapyramidal symptoms at doses ≥2 mg daily 1
- Avoid coadministration with other QT-prolonging medications 1
Aripiprazole evidence:
- 56% positive response on aripiprazole 5 mg versus 35% on placebo in pediatric RCT 1
- Flexibly-dosed 5-15 mg/day demonstrated efficacy in children ages 6-17 1
Critical warnings:
- Typical antipsychotics should NOT be first-line due to higher risk of irreversible tardive dyskinesia 1
- Pimozide requires cardiac monitoring due to significant QT prolongation risk 1
- Avoid benztropine or trihexyphenidyl for managing extrapyramidal symptoms in this population 1
Step 5: Focal Treatment
Botulinum toxin injections can be effective for a few particularly disabling focal motor tics 5, 6
Step 6: Treatment-Refractory Cases
A patient is treatment-refractory ONLY after:
- Failing behavioral techniques (HRT, ERP) AND
- Therapeutic doses of at least 3 proven medications (including anti-dopaminergic drugs AND alpha-2 adrenergic agonists) AND
- Stable, optimized treatment for comorbidities for ≥6 months 1
Deep Brain Stimulation (DBS):
- Reserved exclusively for severe, treatment-refractory cases with significant functional impairment 1
- Recommended only for patients >20 years of age due to uncertainty about spontaneous remission 1
- Targets: centromedian-parafascicular thalamus and globus pallidus interna 1
- Requires comprehensive multidisciplinary assessment 1
Monitoring and Follow-Up
- Assess health-related quality of life using disease-specific instruments (e.g., GTS-QOL) 1
- Monitor treatment adherence and psychosocial factors 1
- Document impact on function and quality of life at each visit 1
Special Consideration: Tic Cough
For chronic cough that remains medically unexplained after comprehensive evaluation, diagnose tic cough when core clinical features are present (suppressibility, distractibility, suggestibility, variability, premonitory sensation) 4
Somatic cough disorder diagnosis requires:
- Extensive evaluation ruling out tic disorders and uncommon causes 4
- Meeting DSM-5 criteria for somatic symptom disorder (distressing symptoms causing life disruption, excessive health anxiety, persistent >6 months) 4
- Treatment: non-pharmacological trials of hypnosis or suggestion therapy, or combinations of reassurance, counseling, or referral to psychologist/psychiatrist 4